I agree with you Lory that management has to be queried...

I agree with you Lory that management has to be queried regarding the performance of the company over the past year.
The HK listing attempt was a disaster costing shareholders millions
and preventing SP rise to the 15th Aug until it was withdrawn.
The massive dilution & CR @ $1.10 sent the SP sub $1 and it has'nt
recovered since.
In the interim the company could have been derisked from an investment
perspective by selling Mt Catlin Spodumene on the open market and publishing the actual cost of production.

Then there was the Mt Catlin & Carbonate plant costs blowout
which leads the investor to ask "what next"?

GXY has now its eggs in one basket by risking the value of the company
on the test results of the carbonate plant due before the end of the month.
If the results are good then the SP will likely top the CR price but if
the results are not good then the SP is likely to drop followed by a quick cheap buyout offer by the Chinese.

Should that happen, those retail shareholders who bought-in above the
$1.10 cr price will be done like a dinner.

Cheers
Moorookamick
Turin.